Table of Contents
Ezetimibe is a medication commonly prescribed to lower cholesterol levels in individuals at risk of cardiovascular disease. Understanding its mechanism of action helps clarify how it contributes to heart health.
Overview of Ezetimibe
Ezetimibe is a selective cholesterol absorption inhibitor. It works primarily in the gastrointestinal tract to prevent the absorption of dietary and biliary cholesterol.
How Ezetimibe Works
The drug targets a specific protein called Niemann-Pick C1-Like 1 (NPC1L1) located on the enterocytes of the small intestine. This protein is responsible for the uptake of cholesterol from the intestinal lumen into the cells.
Inhibition of Cholesterol Absorption
By binding to NPC1L1, ezetimibe blocks the transporter, reducing the amount of cholesterol that enters the bloodstream from the diet. This results in decreased plasma cholesterol levels.
Impact on Liver Cholesterol
The reduction in intestinal cholesterol absorption causes the liver to compensate by increasing the uptake of LDL cholesterol from the blood. Over time, this leads to a decrease in circulating LDL cholesterol levels.
Synergy with Other Cholesterol-Lowering Agents
Ezetimibe is often combined with statins to enhance cholesterol lowering. While statins inhibit cholesterol synthesis in the liver, ezetimibe decreases absorption, providing a complementary mechanism.
Effects on Lipid Profile
Patients taking ezetimibe typically experience significant reductions in low-density lipoprotein (LDL) cholesterol. It may also modestly increase high-density lipoprotein (HDL) cholesterol and lower triglycerides in some cases.
Conclusion
Ezetimibe’s targeted inhibition of intestinal cholesterol absorption via NPC1L1 makes it an effective tool in managing hypercholesterolemia. Its unique mechanism complements other therapies, helping reduce cardiovascular risk.